As of the latest SEC filings, Maze Therapeutics, Inc. (MAZE) is held by 153 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $34,691,371.50 in market value, representing a significant portion of its portfolio.
Funds holding Maze Therapeutics, Inc. (MAZE)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- MAZE
- CIK:
- 0001842295
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $34,691,371.50 | 1,162,190 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.03% | $19,233,220.65 | 644,329 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.27% | $14,218,837.15 | 311,885 | Feb 28, 2026 | Apr 24, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.13% | $8,409,212.27 | 184,453 | Feb 27, 2026 | Apr 24, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $7,013,585.85 | 234,961 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.02% | $6,954,125.40 | 261,630 | Apr 30, 2026 | Jun 26, 2026 |
|
IWN
iShares Russell 2000 Value ETF
|
ETF | BlackRock / iShares | 0.05% | $6,303,096.15 | 211,159 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.07% | $5,908,389.60 | 197,936 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.01% | $5,036,236.12 | 110,468 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.03% | $4,844,256.63 | 106,257 | Feb 28, 2026 | Apr 28, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.02% | $4,651,866.83 | 102,037 | Feb 28, 2026 | Apr 24, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.01% | $4,341,900.42 | 95,238 | Feb 28, 2026 | Apr 24, 2026 |
|
XPH
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
|
ETF | State Street (SPDR) | 1.13% | $3,493,673.85 | 117,041 | Mar 31, 2026 | May 28, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 0.29% | $3,336,215.10 | 111,766 | Mar 31, 2026 | May 29, 2026 |
|
VFMO
VANGUARD U.S. MOMENTUM FACTOR ETF
|
ETF | Vanguard | 0.16% | $2,192,651.05 | 48,095 | Feb 28, 2026 | Apr 28, 2026 |
|
IWC
iShares Micro-Cap ETF
|
ETF | BlackRock / iShares | 0.16% | $1,991,711.40 | 66,724 | Mar 31, 2026 | May 28, 2026 |
|
SBIO
ALPS Medical Breakthroughs ETF
|
ETF | Independent / Boutique | 1.42% | $1,955,309.51 | 42,889 | Feb 28, 2026 | Apr 29, 2026 |
|
DWAS
Invesco Dorsey Wright SmallCap Momentum ETF
|
ETF | Invesco | 0.50% | $1,945,006.17 | 42,663 | Feb 28, 2026 | Apr 28, 2026 |
|
THW
abrdn World Healthcare Fund
|
CEF | abrdn / Aberdeen | 0.37% | $1,785,537.45 | 59,817 | Mar 31, 2026 | May 29, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $1,777,417.33 | 38,987 | Feb 28, 2026 | Apr 24, 2026 |
|
IHE
iShares U.S. Pharmaceuticals ETF
|
ETF | BlackRock / iShares | 0.18% | $1,766,433.45 | 59,177 | Mar 31, 2026 | May 22, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 0.29% | $1,631,123.40 | 54,644 | Mar 31, 2026 | May 29, 2026 |
|
SWSSX
Schwab Small-Cap Index Fund
|
MF | Charles Schwab | 0.02% | $1,544,111.94 | 58,093 | Apr 30, 2026 | Jun 25, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $1,403,898.46 | 30,794 | Feb 28, 2026 | Apr 24, 2026 |
|
BMEZ
BlackRock Health Sciences Term Trust
|
CEF | BlackRock / iShares | 0.13% | $1,335,041.25 | 44,725 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)